$GALE Headlines FutureFuel shares rally on big
Post# of 102932

FutureFuel shares rally on big profit jump 5:20 p.m. March 17, 2014 - Wallace Witkowski
3 best hedge fund managers of 2013 2:50 p.m. Jan. 22, 2014 - Insider Monkey
Top longs and shorts to watch 1:18 p.m. March 6, 2012 - The Trading Deck
20 Cheap Stocks Under $10 Worth Zilch 5:40 a.m. Today - InvestorPlace.com
RXi Pharmaceuticals: Early-Stage Biotech With A Promising Future 5:22 p.m. Aug. 4, 2014 - Seeking Alpha
Galectin Pays Stock Promoters to Entice Retail Investors 12:34 p.m. July 28, 2014 - TheStreet.com
Galena Gives Sales Team Another Useless Product to Promote 9:41 a.m. July 22, 2014 - TheStreet.com
Galena secures U.S. rights to serotonin blocker 8:33 a.m. July 22, 2014 - Seeking Alpha
Galena Biopharma Enters Into Definitive Agreement To License U.S. Rights for Zuplenz Oral Soluble Film - Will Pay $5M In Cash & Stock 6:06 a.m. July 22, 2014 - benzinga.com
Biotech Accused in Stock-Pump Scheme 11:10 a.m. July 8, 2014 - Barrons.com
Trade-Ideas: Galena Biopharma (GALE) Is Today's "Perilous Reversal" Stock 9:49 a.m. July 2, 2014 - TheStreet.com
Galena receives notice of allowance of NeuVax patent 8:14 a.m. July 1, 2014 - Seeking Alpha
Stock To Watch: Galena Biopharma (GALE) In Perilous Reversal 9:52 a.m. June 18, 2014 - TheStreet.com
GALE-301 Phase 2a clinical trial enrollment complete 7:53 a.m. June 17, 2014 - Seeking Alpha
Galena Biopharma (GALE) Marked As A Dead Cat Bounce Stock 10:22 a.m. June 16, 2014 - TheStreet.com
Galena Promoting Experimental Breast Cancer Drug With Faux News Articles Again 10:11 a.m. June 13, 2014 - TheStreet.com
Biotech Stock Hate Mailbag: The Hostile React-o-Meter Meltdown Edition 10:32 a.m. June 6, 2014 - TheStreet.com
The Seven Deadly Sins of Biotech Investing 7:00 a.m. May 29, 2014 - TheStreet.com
Cramer's Lightning Round - ConEd Is Behaving Very Badly (5/21/14) 6:03 a.m. May 22, 2014 - Seeking Alpha
'Mad Money' Lightning Round: I'm Sticking With Con Ed 6:00 a.m. May 22, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: How Stupid Can This Market Be? 7:57 p.m. May 21, 2014 - TheStreet.com
SEC Casting Wide Net in Galena Investigation 3:35 p.m. May 14, 2014 - TheStreet.com
Biotech Stock Mailbag: Sarepta, F-R Rule Stock Predictions, Merrimack 6:00 a.m. May 9, 2014 - TheStreet.com
Biotech Stocks Technical Data -- MannKind, ARIAD Pharma, Galena Biopharma, Geron, and Peregrine Pharma 9:00 a.m. Aug. 1, 2014 - PR Newswire - PRF
Galena Biopharma to Report Second Quarter 2014 Financial Results on Monday, August 11, 2014 7:06 a.m. July 29, 2014 - GlobeNewswire
MonoSol Rx Enters Into Exclusive Licensing Agreement With Galena Biopharma for Zuplenz(R) Oral Soluble Film 7:16 a.m. July 22, 2014 - GlobeNewswire
Galena Biopharma Enters Into Definitive Agreement to License U.S. Rights for Zuplenz(R) (ondansetron) Oral Soluble Film 7:06 a.m. July 22, 2014 - GlobeNewswire
Board Changes, Patents, Recognitions, and Technical Updates - Analyst Notes on Actavis, Celldex Therapeutics, Galena Biopharma, PTC Therapeutics and Theravance Biopharma 5:30 a.m. July 4, 2014 - PR Newswire - PRF
Galena Biopharma Receives Notice of Allowance of Broad U.S. Patent for NeuVax(TM) (nelipepimut-S) 7:06 a.m. July 1, 2014 - GlobeNewswire
Biotechnology Equities Technical Notes -- Research on StemCells, Gilead Sciences, Galena Biopharma, and Inovio Pharma 7:10 a.m. June 26, 2014 - PR Newswire - PRF
New Patents, Clinical Trial Updates, New Agreements, and FDA Approvals - Analyst Notes on Agile Therapeutics, Vanda, Galena, Nanosphere and Rockwell 5:10 a.m. June 26, 2014 - PR Newswire - PRF
Galena Biopharma to Present at the 9th Annual JMP Securities Healthcare Conference 7:05 a.m. June 19, 2014 - GlobeNewswire
Galena Biopharma Recent Events will Continue to Weigh In on Shares, Analyst Report by BrokerBank Securities, Inc. 1:30 p.m. June 17, 2014 - PR Newswire - PRF
Galena Biopharma Completes Enrollment in GALE-301 Phase 2a Clinical Trial in Ovarian and Endometrial Cancers 7:06 a.m. June 17, 2014 - GlobeNewswire
Theralase's Cancer Technology Demonstrates Vaccine-Like Properties 8:04 a.m. June 16, 2014 - ACCESSWIRE
Technical Update, Leadership Appointments, and Clinical Trial Results - Analyst Notes on Achillion, Nektar, CytRx, Galena and Receptos 5:20 a.m. June 12, 2014 - PR Newswire - PRF
Galena Biopharma to Present at the Jefferies 2014 Global Healthcare Conference 7:06 a.m. May 30, 2014 - GlobeNewswire
Top Gainers Technical Coverage -- Research on NeuStar, Signet Jewelers, Galena Biopharma, and Sarepta Therapeutics 9:29 a.m. May 23, 2014 - PR Newswire - PRF
Galena Biopharma to Present at the Marcum MicroCap Conference 7:06 a.m. May 23, 2014 - GlobeNewswire
Galena Biopharma to Present GALE-301 Phase 1 Data at the American Society of Clinical Oncology (ASCO) 50th Annual Meeting 7:06 a.m. May 21, 2014 - GlobeNewswire
GALENA BIOPHARMA, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of Class Action Against GALENA BIOPHARMA, INC. and Its Board and a Lead Plaintiff Deadline of May 5, 2014 1:36 p.m. May 1, 2014 - BusinessWire - BZX
Galena Biopharma to Present at the 39th Annual Deutsche Bank Health Care Conference 7:06 a.m. April 30, 2014 - GlobeNewswire
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders With Losses on Their Investment in Galena Biopharma, Inc. of Class Action Lawsuit and Upcoming Deadline --- GALE 4:02 a.m. April 28, 2014 - GlobeNewswire

